Use of tyrosine kinase inhibitor to treat diabetes

Details for Australian Patent Application No. 2004243491 (hide)

Owner Hagerkvist, R. Richard, W.

Inventors Hagerkvist, Robert Per; Welsh, Nils Richard

Agent Davies Collison Cave

Pub. Number AU-B-2004243491

PCT Pub. Number WO2004/105763

Priority 0402682.9 06.02.04 GB; 0312086.2 27.05.03 GB

Filing date 26 May 2004

Wipo publication date 9 December 2004

Acceptance publication date 3 May 2007

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/404 (2006.01)

A61K 31/42 (2006.01) - Oxazoles

A61K 31/437 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/105763 Priority application(s): WO2004/105763

3 May 2007 Application Accepted

  Published as AU-B-2004243491

30 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243492-Hydrazone derivatives for combatting harmful insects and arachnids

2004243489-Drug delivery systems for tumor targeting NGR-molecules and uses thereof